Program
10:00 "Antibody innovation at UCB - from the top to the tail of IgG"
David Humphreys, Executive Director, Head of Antibody and Novel Therapeutics. UCB Pharma, UK
Abstract: UCB Pharma, and its legacy Celltech have a 30+ year history in antibody innovation. This seminar will share a range of innovations which cover the whole of the IgG molecule, past and present. There will be emphasis on more recent therapeutically focused technologies and projects in the areas of inflammatory immunology and oncology.
11:00 "UiO Growth House – nurturing and empowering tomorrow’s innovators and entrepreneurs"
Sander J. Tufte, Senior Innovation Advisor, UiO Growth House, University of Oslo
11:15 "From Science to Business"
Jens Halvard Grønlien, Vice President Innovation, Inven2
11:30 "From academia to establishment of a science-driven biotech company - Authera"
Simone Mester, CEO, Authera AS